Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
62.96+0.51 (+0.82%)
At close: 04:00PM EDT
62.80 -0.16 (-0.25%)
After hours: 07:51PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • w
    whrutter
    Note to CEO O’Day and the Board - When I make charitable donations, I do it with my own money.
  • S
    Sharbe
    What has O'Day's total compensation been in the over 3 years he's been here? $200 million? And the stock is down 10% since he arrived. In a roaring bull market. Why is he still here and why do some people actually defend him on here? I feel like I live in an alternative universe. Everything is upside down now. Have a good day sailing your yacht today Mr. O'Day.
  • B
    Bruce of Windsor
    Investing in GILD is like quicksand.... The dividend is good but the growth potential is stagnant at best....
  • C
    Cnote
    time for someone to buy GILD
  • M
    Mr. X
    GILD has been a " Dog with fleas" since 2015 ( 7 years) .
    How is this possible that this company cannot sustain a stock price of $80min to $100?
    Why hasn't this CEO been replaced? Makes no sense ?
  • N
    NYSE
    Another O'Day, another down day. How long can he last?
  • S
    Sharbe
    I'm now convinced that Gilead only exists for O'Day's benefit. Show me where I'm wrong.
  • G
    Garrett
    GILD spent $31 BILLION of shareholders' money on oncology drugs that have produced a few hundred million in sales. They've already written off billions of the cost of purchase. And of course, there's zero accountability.
  • S
    Steven
    Your investment in GILD may not make you any money, but just think of how good you feel being part of the WOKEST company. True socialism they take your money and give it away.
    "Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency"
  • K
    Kjinman
    This really irks me. Merck is rumored to buy SGEN for 40B and SGEN runs from $108 in May to it's current $175 even though 40B is equivalent to $217 a share. I would not be surprised if the deal never happens. Why put the article out prior to this deal being a reality??? Why doesn't GILD do the same thing tomorrow. They could say a company like Merck is in advanced talks to but GILD for $175B. Heck, why not!
  • L
    L
    The bearish posts about GILD and O'Day on this board have reached saturation, all while GILD is up while Nasdaq down big. GILD will soon start a huge run-up, as soon as the Calls expire. I will stop selling Calls for a while, and wait abit. I have never been more bullish on GILD as this month. :D :D :D
    Bullish
  • m
    markm
    "higher net unrealized losses from our strategic equity investments....,....". not very strategic
  • S
    Sharbe
    The chart is firming up and looking good. The 200 day moving average is now $64.27. If we take that level out, we should close the gap at $67.91. Of course, there is always the O'Day factor that you need to consider.
  • m
    markm
    bought back $72 m worth of stock in the q, and donated $85m to the Gilead foundation..... great use of shareholder $$$$$...... don't forget mgmt millions in there ..... unreal
  • d
    demetrios
    Basically this company exists to give to charity. Shareholders are always going to be short changed. Wait until 50 to buy it. Ther are much better biotechs like biogen to buy
  • d
    dennis
    Pretty good. The turnaround continues. Sales up 7% without covid. The turn is behind us and the future looks good.
  • S
    Sharbe
    did they fire O'Day?
  • F
    Frank B
    Pfizer purchased Array for $11.4 billion and just stopped phase three trial because it will not meet its primary end point. So tell me again about the Kite and IMMU purchase under the last regime maybe some write off for not being an overnight sensation but the earnings call showed a 71% increase year over year for the same quarter.
  • m
    markm
    they could have retired 50% of outstanding shares for what they blew on failed acquisitions.......unreal.
  • S
    Steven
    Gilead's $5B Galapagos black hole widens as pair tosses out phase 3 asset after flop
    The Street thinks GILD just threw $405 million away.
Advertisement
Advertisement